161 related articles for article (PubMed ID: 1354642)
1. Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR1) gene in individuals with malignant hyperthermia.
Gillard EF; Otsu K; Fujii J; Duff C; de Leon S; Khanna VK; Britt BA; Worton RG; MacLennan DH
Genomics; 1992 Aug; 13(4):1247-54. PubMed ID: 1354642
[TBL] [Abstract][Full Text] [Related]
2. The role of the skeletal muscle ryanodine receptor gene in malignant hyperthermia.
MacLennan DH; Otsu K; Fujii J; Zorzato F; Phillips MS; O'Brien PJ; Archibald AL; Britt BA; Gillard EF; Worton RG
Symp Soc Exp Biol; 1992; 46():189-201. PubMed ID: 1341035
[TBL] [Abstract][Full Text] [Related]
3. A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia.
Gillard EF; Otsu K; Fujii J; Khanna VK; de Leon S; Derdemezi J; Britt BA; Duff CL; Worton RG; MacLennan DH
Genomics; 1991 Nov; 11(3):751-5. PubMed ID: 1774074
[TBL] [Abstract][Full Text] [Related]
4. The genetic basis of malignant hyperthermia.
MacLennan DH
Trends Pharmacol Sci; 1992 Aug; 13(8):330-4. PubMed ID: 1329295
[TBL] [Abstract][Full Text] [Related]
5. Detection of a novel mutation in the ryanodine receptor gene in an Irish malignant hyperthermia pedigree: correlation of the IVCT response with the affected and unaffected haplotypes.
Keating KE; Giblin L; Lynch PJ; Quane KA; Lehane M; Heffron JJ; McCarthy TV
J Med Genet; 1997 Apr; 34(4):291-6. PubMed ID: 9138151
[TBL] [Abstract][Full Text] [Related]
6. Screening of the ryanodine receptor gene in 105 malignant hyperthermia families: novel mutations and concordance with the in vitro contracture test.
Brandt A; Schleithoff L; Jurkat-Rott K; Klingler W; Baur C; Lehmann-Horn F
Hum Mol Genet; 1999 Oct; 8(11):2055-62. PubMed ID: 10484775
[TBL] [Abstract][Full Text] [Related]
7. Mutation screening of the RYR1 gene in malignant hyperthermia: detection of a novel Tyr to Ser mutation in a pedigree with associated central cores.
Quane KA; Keating KE; Healy JM; Manning BM; Krivosic-Horber R; Krivosic I; Monnier N; Lunardi J; McCarthy TV
Genomics; 1994 Sep; 23(1):236-9. PubMed ID: 7829078
[TBL] [Abstract][Full Text] [Related]
8. Ryanodine receptor gene point mutation and malignant hyperthermia susceptibility.
Moroni I; Gonano EF; Comi GP; Tegazzin V; Prelle A; Bordoni A; Bresolin N; Scarlato G
J Neurol; 1995 Feb; 242(3):127-33. PubMed ID: 7751854
[TBL] [Abstract][Full Text] [Related]
9. Discordance, in a malignant hyperthermia pedigree, between in vitro contracture-test phenotypes and haplotypes for the MHS1 region on chromosome 19q12-13.2, comprising the C1840T transition in the RYR1 gene.
Deufel T; Sudbrak R; Feist Y; Rübsam B; Du Chesne I; Schäfer KL; Roewer N; Grimm T; Lehmann-Horn F; Hartung EJ
Am J Hum Genet; 1995 Jun; 56(6):1334-42. PubMed ID: 7762556
[TBL] [Abstract][Full Text] [Related]
10. The substitution of Arg for Gly2433 in the human skeletal muscle ryanodine receptor is associated with malignant hyperthermia.
Phillips MS; Khanna VK; De Leon S; Frodis W; Britt BA; MacLennan DH
Hum Mol Genet; 1994 Dec; 3(12):2181-6. PubMed ID: 7881417
[TBL] [Abstract][Full Text] [Related]
11. A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree.
Brown RL; Pollock AN; Couchman KG; Hodges M; Hutchinson DO; Waaka R; Lynch P; McCarthy TV; Stowell KM
Hum Mol Genet; 2000 Jun; 9(10):1515-24. PubMed ID: 10888602
[TBL] [Abstract][Full Text] [Related]
12. A simple method to detect the RYR1 mutation G1021A, a cause of malignant hyperthermia susceptibility.
Alestrøm A; Fagerlund TH; Berg K
Clin Genet; 1995 May; 47(5):274-5. PubMed ID: 7554356
[TBL] [Abstract][Full Text] [Related]
13. Detection of a novel RYR1 mutation in four malignant hyperthermia pedigrees.
Keating KE; Quane KA; Manning BM; Lehane M; Hartung E; Censier K; Urwyler A; Klausnitzer M; Muller CR; Heffron JJ
Hum Mol Genet; 1994 Oct; 3(10):1855-8. PubMed ID: 7849712
[TBL] [Abstract][Full Text] [Related]
14. A search for three known RYR1 gene mutations in 41 Swedish families with predisposition to malignant hyperthermia.
Fagerlund TH; Islander G; Twetman ER; Berg K
Clin Genet; 1995 Jul; 48(1):12-6. PubMed ID: 7586638
[TBL] [Abstract][Full Text] [Related]
15. Detection of a novel common mutation in the ryanodine receptor gene in malignant hyperthermia: implications for diagnosis and heterogeneity studies.
Quane KA; Keating KE; Manning BM; Healy JM; Monsieurs K; Heffron JJ; Lehane M; Heytens L; Krivosic-Horber R; Adnet P
Hum Mol Genet; 1994 Mar; 3(3):471-6. PubMed ID: 8012359
[TBL] [Abstract][Full Text] [Related]
16. Search for three known mutations in the RYR1 gene in 48 Danish families with malignant hyperthermia.
Fagerlund T; Ording H; Bendixen D; Berg K
Clin Genet; 1994 Dec; 46(6):401-4. PubMed ID: 7889656
[TBL] [Abstract][Full Text] [Related]
17. Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia.
MacLennan DH; Duff C; Zorzato F; Fujii J; Phillips M; Korneluk RG; Frodis W; Britt BA; Worton RG
Nature; 1990 Feb; 343(6258):559-61. PubMed ID: 1967823
[TBL] [Abstract][Full Text] [Related]
18. Identification of heterozygous and homozygous individuals with the novel RYR1 mutation Cys35Arg in a large kindred.
Lynch PJ; Krivosic-Horber R; Reyford H; Monnier N; Quane K; Adnet P; Haudecoeur G; Krivosic I; McCarthy T; Lunardi J
Anesthesiology; 1997 Mar; 86(3):620-6. PubMed ID: 9066328
[TBL] [Abstract][Full Text] [Related]
19. Malignant hyperthermia--a large kindred linked to the RYR1 gene.
Wallace AJ; Wooldridge W; Kingston HM; Harrison MJ; Ellis FR; Ford PM
Anaesthesia; 1996 Jan; 51(1):16-23. PubMed ID: 8669559
[TBL] [Abstract][Full Text] [Related]
20. A cysteine-for-arginine substitution (R614C) in the human skeletal muscle calcium release channel cosegregates with malignant hyperthermia.
Hogan K; Couch F; Powers PA; Gregg RG
Anesth Analg; 1992 Sep; 75(3):441-8. PubMed ID: 1510267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
